Curi Bio, a leader in delivering human functional data to drug discoverers through advanced preclinical tissue models, is proud to announce its selection as one of Deloitte’s Technology Fast 500™ companies in 2024, an annual ranking of the 500 fastest-growing technology companies in North America. Curi Bio achieved an overall rank of #123 and secured #18 out of the 70 life sciences companies recognized, highlighting its transformative contribution to enabling the development of next-generation medicines. Curi Bio’s innovative human stem cell platforms deliver functional data that enable biopharmaceutical researchers to make better informed, data-driven decisions during preclinical drug development.
“We are honored to be recognized among North America’s most innovative and fastest-growing life sciences companies,” said Dr. Nicholas A. Geisse, CEO at Curi Bio. “This recognition reflects the unyielding dedication of our team and the groundbreaking impact of our human-relevant platforms. By providing drug developers tools that more accurately replicate human physiology, our work has accelerated timelines and continues improving the safety and efficacy of new therapies for patients suffering from some of the world’s most devastating diseases.”
Top global pharmaceutical companies have rapidly adopted Curi Bio’s biological models, driving the company’s strong and steady revenue growth. By delivering predictive, clinically relevant insights, Curi Bio’s technology accelerates the development of safer and more effective drugs, addressing critical challenges in a rapidly evolving industry. The company’s portfolio of functional human disease models spans cardiac, skeletal muscle, and neuromuscular indications, offering researchers powerful tools to tackle some of the most complex diseases beyond the constraints of costly and risky clinical trials. This approach of empowering researchers with turnkey platforms has been a cornerstone of Curi Bio’s growth, earning recognition with this award and demonstrating its pivotal role in advancing medical science.
Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!
